Tech Company Financing Transactions
SoluLink Funding Round
Private investors participated in a $1 million capital raise for SoluLink. This venture round was announced on 11/22/2011.
Transaction Overview
Company Name
Announced On
11/22/2011
Transaction Type
Debt
Amount
$1,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
9853 Pacific Heights Blvd. H
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
SoluLinK specializes in developing and manufacturing high quality, cutting-edge conjugation reagents, and associated products and services for all bioscience applications. We are committed to providing the most comprehensive panel of high quality research reagents at the most reasonable prices.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jack Ball
President
Steve DeGraw
VP - Product Management
Xinfang Zhao
VP - R & D
Jim Williams
Browse more venture capital transactions:
Prev: 11/22/2011: Remedy Pharmaceuticals venture capital transaction
Next: 11/22/2011: Portola Pharmaceuticals venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs